Newron Pharmaceuticals S.p.A et al v. MSN Laboratories Private Limited et al
| Newron Pharmaceuticals S.p.A., MDD US Operations, LLC and Zambon S.p.A. |
| Aurobindo Pharma USA Inc., Prinston Pharmaceutical, Inc., MSN Laboratories Private Limited, Zenara Pharma Private Limited, RK Pharma, Inc., Optimus Pharma Pvt Ltd and Aurobindo Pharma Limited |
| 1:2021cv00843 |
| June 10, 2021 |
| U.S. District Court for the District of Delaware |
| Richard G Andrews |
| Gregory B Williams |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| Plaintiff |
Docket Report
This docket was last retrieved on June 21, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Pro Hac Vice Attorney Bonnie Fletcher Price for MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
|
Filing 271
MOTION for Fish & Richardson P.C. to Withdraw as Attorney - filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Gupta Fiorella, Nitika)
|
Filing 270
ORAL ORDER: IT IS HEREBY ORDERED that the Status Conference scheduled for October 6, 2023 is RESCHEDULED for October 5, 2023 at 9:00 AM. ORDERED by Judge Gregory B. Williams on 6/14/23. (ntl)
|
Filing 269
NOTICE OF SERVICE of Defendants Notice of Deposition to Allen Reitz filed by Prinston Pharmaceutical, Inc..(Weinblatt, Richard)
|
SO ORDERED, re #268 MOTION for Pro Hac Vice Appearance of Attorney Bonnie Fletcher Price filed by Newron Pharmaceuticals S.p.A., MDD US Operations, LLC, Zambon S.p.A. Signed by Judge Gregory B. Williams on 6/8/23. (ntl)
|
Filing 268
MOTION for Pro Hac Vice Appearance of Attorney Bonnie Fletcher Price - filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Farnan, Michael)
|
Filing 267
NOTICE of Change of Firm Affiliation of Elizabeth Flanagan by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A. (Farnan, Michael)
|
Filing 266
NOTICE of Appearance by Michael J. Farnan on behalf of MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A. (Farnan, Michael)
|
Filing 265
NOTICE of Appearance by Brian E. Farnan on behalf of MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A. (Farnan, Brian)
|
Filing 264
NOTICE OF SERVICE of Defendants Notice of Deposition to John Timothy Greenamyre filed by Prinston Pharmaceutical, Inc..(Weinblatt, Richard)
|
Filing 263
NOTICE to Take Deposition of Ngoc Ngo on June 29, 2023 filed by Prinston Pharmaceutical, Inc., RK Pharma, Inc., Zenara Pharma Private Limited.(Dorsney, Kenneth)
|
Filing 262
NOTICE to Take Deposition of Michele Tagliati on June 26, 2023 filed by Zenara Pharma Private Limited.(Delcollo, Renee)
|
Filing 261
NOTICE OF SERVICE of Defendants RK Pharma and Prinston's Reply Expert Report of Ron Bihovsky regarding Invalidity and Related Document Production filed by RK Pharma, Inc..(Dorsney, Kenneth)
|
Filing 260
NOTICE OF SERVICE of Reply Expert Report of Samuel Pleasure, M.D., Ph.D. filed by Prinston Pharmaceutical, Inc..(Weinblatt, Richard)
|
Filing 259
NOTICE OF SERVICE of Reply Expert Report of Allen B. Reitz, Ph.D. Regarding Infringement of the '485 and '515 Patents by Prinston Pharmaceutical, Inc. and Reply Expert Report of Michele Tagliati, M.D. Regarding Infringement of U.S. Patent No. 8,283,380 filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Booker, Gregory)
|
Filing 258
NOTICE OF SERVICE of Notice of Deposition of Peter LeWitt, M.D. filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 257
NOTICE OF SERVICE of Plaintiffs' Notice of Deposition of Samuel Pleasure and Plaintiffs' Notice of Deposition of Ronald Bihovsky filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 256
REDACTED VERSION of #251 Stipulation, and [Proposed Order] Regarding Defendant MSN Laboratories Private Limited's Infringement of the Asserted '515 and '485 Patents by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Gupta Fiorella, Nitika)
|
Filing 255
NOTICE OF SERVICE of Rebuttal Expert Report of Peter LeWitt, M.D., on the Noninfringement of the '380 Patent by Defendants Prinston, RK Pharma, and Zenara filed by Zenara Pharma Private Limited.(Delcollo, Renee)
|
SO ORDERED, re #253 STIPULATION TO EXTEND TIME for Redactions to D.I. 251 to May 2, 2023 filed by Newron Pharmaceuticals S.p.A., MDD US Operations, LLC, Zambon S.p.A. Signed by Judge Gregory B. Williams on 5/2/23. (ntl)
|
Filing 254
NOTICE OF SERVICE of Rebuttal Expert Report of Ron Bihovsky, Ph.D. on Non-Infringement of U.S. Patent Nos. 8,076,515 and 8,278,485 by Prinston Pharmaceutical, Inc. filed by Prinston Pharmaceutical, Inc..(Weinblatt, Richard)
|
Filing 253
STIPULATION TO EXTEND TIME for Redactions to D.I. 251 to May 2, 2023 - filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Booker, Gregory)
|
Filing 252
NOTICE OF SERVICE of Confidential Expert Report of Ngoc Ngo on Commercial Success; Rebuttal Expert Report of John Timothy Greenamyre to MSN Laboratories Private Limited; Confidential Rebuttal Expert Report of Allen Reitz, and Rebuttal Expert Report of John Timothy Greenamyre to Prinston Pharmaceutical, Inc.; Confidential Rebuttal Expert Report of Allen Reitz, and Rebuttal Expert Report of John Timothy Greenamyre to RK Pharma Inc.; Rebuttal Expert Report of John Timothy Greenamyre to Zenara Pharma Private Limited filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
SO ORDERED, re #251 STIPULATION and Order Regarding Defendant MSN Laboratories Private Limited's Infringement of the Asserted '515 and '485 Patents filed by Newron Pharmaceuticals S.p.A., MDD US Operations, LLC, Zambon S.p.A. Signed by Judge Gregory B. Williams on 4/25/23. (ntl)
|
Filing 251
[SEALED] STIPULATION Regarding Defendant MSN Laboratories Private Limited's Infringement of the Asserted '515 and '485 Patents by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Gupta Fiorella, Nitika)
|
Filing 250
ORDER re #249 Memorandum Opinion regarding claim construction. Signed by Judge Gregory B. Williams on 4/14/23. (ntl)
|
Filing 249
MEMORANDUM OPINION re claim construction. Signed by Judge Gregory B. Williams on 4/14/23. (ntl)
|
Filing 248
NOTICE OF SERVICE of Defendants RK Pharma and Prinston's Opening Expert Report of Ron Bihovsky regarding Invalidity and Related Document Production filed by RK Pharma, Inc..(Hitch, Cortlan)
|
Filing 247
NOTICE OF SERVICE of (1) Confidential Opening Expert Report of Michele Tagliati, Confidential Opening Expert Report of Allen Reitz to MSN Laboratories Private Limited; (2) Confidential Opening Expert Report of Michele Tagliati, Confidential Opening Expert Report of Allen Reitz to Prinston Pharmaceutical, Inc.; (3) Confidential Opening Expert Report of Michele Tagliati, Confidential Opening Expert Report of Allen Reitz to RK Pharma Inc.; (4) Confidential Opening Expert Report of Michele Tagliati, Confidential Opening Expert Report of Allen Reitz to Zenara Pharma Private Limited filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 246
ORAL ORDER: Counsel having indicated by letter (D.I. 245) that a discovery teleconference is no longer needed, IT IS HEREBY ORDERED that the discovery teleconference scheduled for March 28, 2023 is CANCELLED. ORDERED by Judge Gregory B. Williams on 3/27/23. (ntl)
|
Filing 245
Letter to Honorable Gregory B. Williams from Nitika Gupta Fiorella and Carl D. Neff regarding the discovery conference scheduled for March 28, 2023 is no longer required - re 244 Order Setting Teleconference,,,. (Gupta Fiorella, Nitika)
|
Filing 244
ORAL ORDER: IT IS HEREBY ORDERED that a thirty (30) minute discovery teleconference will be held on Tuesday, March 28 at 3:00 p.m. The parties shall arrange for the teleconference and shall provide chambers with the call-in information. IT IS FURTHER ORDERED that, not later than Tuesday, March 21, any party seeking relief shall file with the Court a letter, not to exceed three (3) pages, outlining the issues in dispute and its position on those issues. Not later than Friday, March 24, any party opposing the application for relief may file a letter, not to exceed three (3) pages, outlining that party's reasons for its opposition. Should the Court find further briefing necessary upon conclusion of the telephone conference, the Court will order it. Alternatively, the Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Gregory B. Williams on 3/7/23. (ntl)
|
SO ORDERED, re #243 STIPULATION TO EXTEND TIME to Complete Depositions of Defendant MSN to March 17, 2023 filed by Newron Pharmaceuticals S.p.A., MDD US Operations, LLC, Zambon S.p.A., #242 STIPULATION TO EXTEND TIME for the Completion of Discovery to March 10, 2023 filed by Newron Pharmaceuticals S.p.A., MDD US Operations, LLC, Zambon S.p.A. Signed by Judge Gregory B. Williams on 3/3/23. (ntl)
|
Filing 243
STIPULATION TO EXTEND TIME to Complete Depositions of Defendant MSN to March 17, 2023 - filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Gupta Fiorella, Nitika)
|
Filing 242
STIPULATION TO EXTEND TIME for the Completion of Discovery to March 10, 2023 - filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Gupta Fiorella, Nitika)
|
Filing 241
NOTICE OF SERVICE of Plaintiffs' Confidential Third Supplemental Objections and Responses to Defendants' First Set of Common Interrogatories (No. 1) filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 240
NOTICE OF SERVICE of Plaintiffs' Confidential Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories (No. 6) filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 239
Letter to Honorable Gregory B. Williams from Nitika Gupta Fiorella and Carl D. Neff regarding Scheduling of Discovery Teleconference. (Gupta Fiorella, Nitika)
|
Filing 238
NOTICE OF SERVICE of Defendant Prinstons Amended Objections and Responses to Plaintiffs Second Set of Requests for Admission to Prinston (Nos. 13-19) filed by Prinston Pharmaceutical, Inc..(Weinblatt, Richard)
|
Filing 237
NOTICE OF SERVICE of Plaintiffs' Second Supplemental Objections and Responses to Defendants' First Set of Common Interrogatories (No. 2) filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 236
NOTICE OF SERVICE of Plaintiffs' Amended Notice of Deposition of Sonal Jagani, Plaintiffs' Amended Notice of Deposition of Raghu Kasu, and Plaintiffs' Amended Notice of Deposition of Ravishanker Kovi filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 235
NOTICE OF SERVICE of Plaintiffs' Confidential Second Supplemental Objections and Responses to Defendants' First Set of Common Interrogatories (Nos. 1 and 3) filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 234
NOTICE OF SERVICE of Defendant RK Pharma, Inc.'s Second Supplemental Rule 26(a)(1) Initial Disclosures filed by RK Pharma, Inc..(Dorsney, Kenneth)
|
Filing 233
NOTICE OF SERVICE of Plaintiffs' Third Amended Initial Disclosures to MSN Laboratories Private Limited; Plaintiffs' Third Amended Initial Disclosures to Prinston Pharmaceutical, Inc., Plaintiffs' Third Amended Initial Disclosures to RK Pharma Inc., and Plaintiffs' Third Amended Initial Disclosures to Zenara Pharma Private Limited filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 232
NOTICE OF SERVICE of Plaintiffs' Second Supplemental Objections and Responses to Defendants' First Set of Common Interrogatories (Nos. 7-10) filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 231
NOTICE OF SERVICE of Plaintiffs' Amended Notice of Deposition of Mahaboob Dowla, Plaintiffs' Amended Notice of Deposition of Praveen Kumar, and Plaintiffs' Amended Notice of Deposition of Bhaskar Reddy filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 230
NOTICE OF SERVICE of Defendant MSN's Privilege Log filed by MSN Laboratories Private Limited.(Neff, Carl)
|
Filing 229
NOTICE OF SERVICE of Defendant RK Pharma, Inc.'s Privilege Log filed by RK Pharma, Inc..(Dorsney, Kenneth)
|
Filing 228
NOTICE OF SERVICE of Newron Pharmaceuticals S.p.A.'s Privilege Log, Zambon S.p.A.'s Privilege Log, and MDD US Operations, LLC Privilege Log filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 227
NOTICE OF SERVICE of RK Pharma's response to Plaintiffs' First Set of Requests for Admission (Nos. 1-7) filed by RK Pharma, Inc..(Dorsney, Kenneth)
|
Filing 226
NOTICE OF SERVICE of Defendant MSN's Responses & Objections to Plaintiffs' Amended 30(b)(6) Deposition Notice filed by MSN Laboratories Private Limited.(Neff, Carl)
|
Filing 225
NOTICE OF SERVICE of Defendant Prinstons Objections and Responses to Plaintiffs Second Set of Request for Admission to Prinston (Nos. 13-19) filed by Prinston Pharmaceutical, Inc..(Weinblatt, Richard)
|
Filing 224
NOTICE OF SERVICE of Defendant MSN Responses and Objections to Plaintiffs First Set of Individual Interrogatories (Nos. 1-2), Responses and Objections to Plaintiffs First Set of Requests for Admission (Nos. 1-7), and Second Supplemental Responses and Objections to Plaintiffs First Set of Common Interrogatories (Nos. 6 and 7) filed by MSN Laboratories Private Limited.(Neff, Carl)
|
Filing 223
NOTICE OF SERVICE of (1) Defendant Zenara Pharma Private Limited's Objections and Responses to Plaintiff's Third Set of Requests for Production; (2) Defendant Zenara Pharma Private Limited's Objections and Responses to Plaintiffs' First Set of Requests for Admission filed by Zenara Pharma Private Limited.(Delcollo, Renee)
|
Filing 222
NOTICE OF SERVICE of Defendant Prinston Pharmaceutical, Inc.s Revised Initial Disclosures Pursuant to Rule 26(a)(1) filed by Prinston Pharmaceutical, Inc..(Weinblatt, Richard)
|
Filing 221
NOTICE OF SERVICE of Defendant RK Pharma, Inc.'s Second Supplemental Response to Plaintiffs' Interrogatory No. 7 filed by RK Pharma, Inc..(Hitch, Cortlan)
|
Filing 220
NOTICE OF SERVICE of Plaintiffs' Notice of Deposition of Dr. Jayaraman Kannapan filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 219
NOTICE OF SERVICE of Plaintiffs' First Supplemental Objections and Responses to Defendants' Second Set of Common Interrogatories (No. 12) filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 218
NOTICE OF SERVICE of Defendant Zenara Pharma Private Limited's Objections and Responses to Plaintiffs' Notice of Deposition of Defendants Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Zenara Pharma Private Limited.(Schladweiler, Benjamin)
|
Filing 217
NOTICE OF SERVICE of Defendant RK Pharma Inc.'s Responses and Objections to Plaintiffs Notice of 30(b)(6) Deposition filed by RK Pharma, Inc..(Dorsney, Kenneth)
|
Filing 216
NOTICE OF SERVICE of Defendant Prinstons Supplemental Objections and Responses to Plaintiffs First Set of Common Interrogatories (Nos. 1-7) filed by Prinston Pharmaceutical, Inc..(Weinblatt, Richard)
|
SO ORDERED, re #215 Stipulation of Dismissal filed by Newron Pharmaceuticals S.p.A., MDD US Operations, LLC, Zambon S.p.A. -- Party Aurobindo Pharma Limited, Aurobindo Pharma USA Inc. terminated. Attorney R. Touhey Myer; Michael P. Hogan and Timothy H. Kratz terminated. Signed by Judge Gregory B. Williams on 1/5/23. (ntl)
|
Filing 215
STIPULATION of Dismissal of Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Gupta Fiorella, Nitika)
|
Filing 214
NOTICE OF SERVICE of Plaintiffs' Amended Notice of Rule 30(b)(6) Deposition of MSN Laboratories Private Limited filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Booker, Gregory)
|
Filing 213
NOTICE OF SERVICE of Plaintiffs' 30(b)(6) Notice of Deposition of Aurobindo Pharma Limited and Aurobindo Pharma USA Inc.; Plaintiffs' 30(b)(6) Notice of Deposition to Zenara Pharma Private Limited; and Plaintiffs' 30(b)(1) Notices of Deposition of Bhaskar Reddy, Mahaboob Dowla, and Praveen Kumar filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 212
NOTICE OF SERVICE of (1) Plaintiffs' Supplemental Claim Charts and Plaintiffs' First Set of Requests for Admissions to Aurobindo Pharma Limited and Aurobindo Pharma USA Inc. Nos. 1-7; (2) Plaintiffs' Supplemental Claim Charts, Plaintiffs' First Set of Individual Interrogatories Nos. 1-2, and Plaintiffs' First Set of Requests for Admissions to MSN Laboratories Private Limited Nos. 1-7; (3) Plaintiffs' Second Supplemental Claim Charts and Plaintiffs' Second Set of Requests for Admissions to Prinston Pharmaceutical, Inc. Nos. 13-19; (4) Plaintiffs' Supplemental Claim Charts and Plaintiffs' First Set of Requests for Admissions to RK Pharma Inc. Nos. 1-7; and (5) Plaintiffs' Supplemental Claim Charts, Plaintiffs' First Set of Requests for Admissions Nos. 1-7, and Plaintiffs' Third Set of Requests for Production Nos. 48-49 to Zenara Pharma Private Limited filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 211
ORDER to Amend Scheduling Order. Signed by Judge Gregory B. Williams on 12/28/2022. (etg)
|
Remark: The Court had to adjust the Amended Schedule proposed by the parties in order to leave sufficient time to decide Daubert motions. If the parties want to agree not to file Daubert motions, then the Court is willing to expand the Expert Discovery period. (etg)
|
Filing 210
STIPULATION and [Proposed] Order to Amend Scheduling Order re #47 Scheduling Order,, by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Gupta Fiorella, Nitika)
|
Filing 209
NOTICE OF SERVICE of Plaintiffs' Notices of 30(b)(1) Depositions and Notice of Rule 30(b)(6) Deposition of MSN Laboratories Private Limited filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 208
NOTICE OF SERVICE of Plaintiffs' Second Supplemental Objections and Responses to Defendants' First Set of Common Interrogatories to RK Pharma (No. 2) filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 207
NOTICE OF SERVICE of Notices of Deposition filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 206
NOTICE OF SERVICE of Plaintiffs' Second Amended Initial Disclosures filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 205
NOTICE OF SERVICE of Defendant RK Pharma Inc.'s Supplemental 26(a)(1) Disclosures filed by RK Pharma, Inc..(Dorsney, Kenneth)
|
Minute Entry for proceedings held before Judge Gregory B. Williams - Markman Hearing held on 12/1/2022. (Court Reporter M. Rolfe.) (ntl)
|
Filing 204
MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan - filed by RK Pharma, Inc.. (Dorsney, Kenneth)
|
SO ORDERED, re #204 MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan filed by RK Pharma, Inc. Signed by Judge Gregory B. Williams on 11/28/2022. (etg)
|
Filing 203
NOTICE OF SERVICE of Plaintiffs' 30(b)(6) Notice of Deposition of RK Pharma filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 202
NOTICE OF SERVICE of Plaintiffs' 30(b)(6) Notice of Deposition on Prinston, Notice of Deposition of Hongchun Qiu and Notice of Deposition of Lijie Wang filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
SO ORDERED, re #197 STIPULATION TO EXTEND TIME for Defendant Zenara Pharma Private Limited to substantially complete document production to November 30, 2022 filed by Zenara Pharma Private Limited. Signed by Judge Gregory B. Williams on 11/15/22. (ntl)
|
Filing 201
NOTICE OF SERVICE of Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.'s Second Supplemental Responses and Objections to Plaintiffs' Second Set of Common Interrogatories to Defendants (No. 8) filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Myer, R.)
|
Filing 200
NOTICE OF SERVICE of RK Pharma's Second Supplemental Response to Plaintiffs' Second Set of Common Interrogatories (No. 8) filed by RK Pharma, Inc..(Dorsney, Kenneth)
|
Filing 199
Supplemental STATEMENT re 184 Oral Order,,,,,,, Terminate Hearings,,,,,,, Set Hearings,,,,,, by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Gupta Fiorella, Nitika)
|
Filing 198
Supplemental STATEMENT re 184 Oral Order,,,,,,, Terminate Hearings,,,,,,, Set Hearings,,,,,, Defendants' Supplemental Claim Construction Statement by Prinston Pharmaceutical, Inc.. (Weinblatt, Richard)
|
Filing 197
STIPULATION TO EXTEND TIME for Defendant Zenara Pharma Private Limited to substantially complete document production to November 30, 2022 - filed by Zenara Pharma Private Limited. (Schladweiler, Benjamin)
|
Filing 196
NOTICE OF SERVICE of Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.'s Third Supplemental Responses and Objections to Plaintiffs' First Set of Common Interrogatories to Defendants (No. 1) filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Myer, R.)
|
Filing 195
NOTICE OF SERVICE of RK Pharma's Second Supplemental Response to Plaintiffs' First Set of Common Interrogatories (No. 1) filed by RK Pharma, Inc..(Hitch, Cortlan)
|
SO ORDERED, re #187 STIPULATION TO EXTEND TIME for Defendant Zenara Pharma Private Limited to substantially complete document production to November 14, 2022 filed by Zenara Pharma Private Limited, #188 STIPULATION TO EXTEND TIME for Defendant MSN to substantially complete document production to November 14, 2022 filed by MSN Laboratories Private Limited. Signed by Judge Gregory B. Williams on 11/1/22. (ntl)
|
Filing 194
NOTICE OF SERVICE of Defendant Prinstons Objections and Responses to Plaintiffs Third Set of Common Interrogatories (Nos. 9) and Defendant Prinstons Objections and Responses to Plaintiffs First Set of Requests for Admission to Prinston (Nos. 1-12) filed by Prinston Pharmaceutical, Inc..(Weinblatt, Richard)
|
Filing 193
NOTICE OF SERVICE of Defendant Prinstons Supplemental Objections and Responses to Plaintiffs Second Set of Common Interrogatories (Nos. 8) filed by Prinston Pharmaceutical, Inc..(Weinblatt, Richard)
|
Filing 192
NOTICE OF SERVICE of Defendant Zenara Pharma Private Limited's Objections and Response to Plaintiffs Third Set of Common Interrogatories (No. 9) and Defendant Zenara Pharma Private Limited's Supplemental Objections and Response to Plaintiffs Second Set of Common Interrogatories (No. 8) filed by Zenara Pharma Private Limited.(Schladweiler, Benjamin)
|
Filing 191
NOTICE OF SERVICE of Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.'s Response and Objections to Plaintiffs' Third Set of Common Interrogatories (No. 9) filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Myer, R.)
|
Filing 190
NOTICE OF SERVICE of RK Pharma's response to Plaintiffs' Third Set of Common Interrogatories (No. 9) filed by RK Pharma, Inc..(Dorsney, Kenneth)
|
Filing 189
NOTICE OF SERVICE of Defendant MSN Supplemental Response and Objections to Plaintiffs Second Set of Common Interrogatories (No. 8) and Response and Objections to Plaintiffs Third Set of Common Interrogatories (No. 9) filed by MSN Laboratories Private Limited.(Neff, Carl)
|
Filing 188
STIPULATION TO EXTEND TIME for Defendant MSN to substantially complete document production to November 14, 2022 - filed by MSN Laboratories Private Limited. (Neff, Carl)
|
Filing 187
STIPULATION TO EXTEND TIME for Defendant Zenara Pharma Private Limited to substantially complete document production to November 14, 2022 - filed by Zenara Pharma Private Limited. (Schladweiler, Benjamin)
|
SO ORDERED, re #185 STIPULATION TO EXTEND TIME for Defendant Zenara Pharma Private Limited to substantially complete document production to October 31, 2022 filed by Zenara Pharma Private Limited. Signed by Judge Gregory B. Williams on 10/17/22. (ntl)
|
Filing 186
NOTICE OF SERVICE of Plaintiffs' First Amended Initial Disclosures filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 185
STIPULATION TO EXTEND TIME for Defendant Zenara Pharma Private Limited to substantially complete document production to October 31, 2022 - filed by Zenara Pharma Private Limited. (Schladweiler, Benjamin)
|
Filing 184
ORAL ORDER: The Markman Hearing is now rescheduled for Thursday, December 1, 2022 at 10:00 AM in Courtroom 6B. Upon review of the parties' claim construction materials (D.I. 120, 133, 134, 180, 181), the Court requires further information with respect to the parties' positions on how a person of ordinary skill in the art would have understood the terms (which are claimed to be indefinite) to mean at the time of the filing of the patent application. Accordingly, IT IS FURTHER ORDERED that, on or before Monday, November 14, 2022, plaintiff and defendants shall each provide the Court with either (a) a supplemental submission in support of the parties' respective positions as to indefiniteness or definiteness containing citations to the specification and prosecution history, or (b) inform the Court that the party will provide live witness(es) at the Markman Hearing to testify as to how a person of ordinary skill in the art would have understood the terms (which are claimed to be indefinite) to mean at the time of the filing of the patent application and where and how the claims, read in light of the specification and prosecution history, inform or fail to inform, with reasonable certainty those skilled in the art about the scope of the invention. On or before Monday, October 31, 2022, plaintiff and defendants shall inform each other as to whether a supplemental submission or live testimony will be provided to the Court. Ordered by Judge Gregory B. Williams on 10/07/2022. (etg)
|
Filing 183
Letter to The Honorable Gregory B. Williams from Gregory R. Booker regarding Rescheduling Claim Construction Hearing. (Booker, Gregory)
|
SO ORDERED, re #182 STIPULATION TO EXTEND TIME for Defendants, Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc., to Substantially Complete Document Production to October 31, 2022 filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. Signed by Judge Gregory B. Williams on 10/7/2022. (etg)
|
Filing 182
STIPULATION TO EXTEND TIME for Defendants, Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc., to Substantially Complete Document Production to October 31, 2022 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Myer, R.)
|
Filing 181
Letter to The Honorable Gregory B. Williams from Gregory R. Booker regarding Amended Joint Claim Construction Chart - re #180 Amended Document. (Booker, Gregory)
|
Filing 180
AMENDED DOCUMENT by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. Amendment to #120 Claim Construction Chart,, Amended Joint Claim Construction Chart. (Booker, Gregory)
|
Filing 179
NOTICE OF SERVICE of Defendant Prinstons Supplemental Objections and Responses to Plaintiffs First Set of Common Interrogatories (Nos. 1-7) filed by Prinston Pharmaceutical, Inc..(Weinblatt, Richard)
|
Filing 178
NOTICE OF SERVICE of Defendant RK Pharma Inc.'s Supplemental responses to Plaintiffs First Set of Common Interrogatories (Nos. 2, 4, 5, & 6) filed by RK Pharma, Inc..(Dorsney, Kenneth)
|
SO ORDERED, re #174 STIPULATION TO EXTEND TIME for Defendant MSN Laboratories Private Limited to substantially complete document production to October 31, 2022 filed by Newron Pharmaceuticals S.p.A., MDD US Operations, LLC, Zambon S.p.A. Signed by Judge Gregory B. Williams on 9/30/22. (ntl)
|
Filing 177
NOTICE OF SERVICE of Defendant Prinstons Objections and Responses to Plaintiffs Second Set of Requests for Production (Nos. 51-52) filed by Prinston Pharmaceutical, Inc..(Weinblatt, Richard)
|
Filing 176
NOTICE OF SERVICE of Defendant MSN's Responses and Objections to Plaintiffs Second Set of Requests for Production (Nos. 46-47) filed by MSN Laboratories Private Limited.(Neff, Carl)
|
Filing 175
NOTICE OF SERVICE of Plaintiffs' First Set of Requests For Admission to Defendant Prinston Pharmaceutical, Inc. filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 174
STIPULATION TO EXTEND TIME for Defendant MSN Laboratories Private Limited to substantially complete document production to October 31, 2022 - filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Gupta Fiorella, Nitika)
|
Filing 173
NOTICE OF SERVICE of Plaintiffs' Third Set of Common Interrogatories to Defendants (No. 9) filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 172
Letter to The Honorable Gregory B. Williams from R Touhey Myer regarding Claim Construction Hearing - re 168 Order,,. (Myer, R.)
|
SO ORDERED, re #170 STIPULATION TO EXTEND TIME for Defendant Zenara Pharma Private Limited to substantially complete document production to October 14, 2022 filed by Zenara Pharma Private Limited. Signed by Judge Gregory B. Williams on 9/30/22. (ntl)
|
Filing 171
ORDER Granting Plaintiffs' Motion to Compel Discovery. Signed by Judge Gregory B. Williams on 9/29/22. (ntl)
|
Filing 170
STIPULATION TO EXTEND TIME for Defendant Zenara Pharma Private Limited to substantially complete document production to October 14, 2022 - filed by Zenara Pharma Private Limited. (Schladweiler, Benjamin)
|
Minute Entry for proceedings held before Judge Gregory B. Williams - Discovery Conference (in court) held on 9/29/2022. (Court Reporter M. Rolfe.) (ntl)
|
Filing 169
NOTICE OF SERVICE of Defendant Zenara Pharma Private Limited's Objections and Responses to Plaintiffs' Second Set of Requests for Production (Nos. 46-47) filed by Zenara Pharma Private Limited.(Schladweiler, Benjamin)
|
Filing 168
ORAL ORDER: Construing Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA's September 28, 2022 letter as a request to appear at the October 12, 2022 Claim Construction Hearing without being represented by Delaware counsel, that request is DENIED. By September 30, 2022, counsel for Defendants shall file with the Court a letter either identifying Delaware counsel who will be present on behalf of Defendants, or otherwise explaining why Defendants are unable to secure any other Delaware counsel to attend. ORDERED by Judge Gregory B. Williams on 9/28/22. (ntl)
|
Filing 167
Letter to The Honorable Gregory B. Williams from R Touhey Myer regarding September 29, 2022 Discovery Conference. (Myer, R.)
|
Filing 166
Letter to The Honorable Gregory B. Williams from R Touhey Myer regarding Claim Construction Hearing. (Myer, R.)
|
Filing 165
REDACTED VERSION of #162 Letter, to Judge Williams in Support of Plaintiffs' Motion to Compel Documents by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Attachments: #1 Exhibits 1-5)(Gupta Fiorella, Nitika)
|
Filing 164
ORAL ORDER: Consistent with the Court Order granting the Joint Motion for Claim Construction (D.I. 135), the Court is setting aside two (2) hours for the Markman hearing with the time split equally between the two sides. Any slide presentations the parties wish to use during the hearing shall be emailed (in PDF format) to [email protected] no later than 48 hours prior to the hearing with hard copies delivered to the Clerk's office within one hour thereafter. IT IS FURTHER ORDERED that, on or before October 5, 2022, local and lead counsel (i.e., those attorneys that will be leading trial) for the parties shall meet and confer and file an amended joint claim construction chart that sets forth the terms that remain in dispute. The meet and confer shall focus on an attempt to reach agreement on any remaining disputed terms where possible and on an attempt to focus the dispute over the remaining terms in light of the joint claim construction brief. Accompanying any amended joint claim construction chart, the parties shall file a letter with the Court identifying by name each individual who participated in the meet and confer, when and how that meet and confer occurred and how long it lasted. If no agreements on constructions have been reached or if no dispute has been narrowed during the meet and confer, the letter shall so state. ORDERED by Judge Gregory B. Williams on 9/22/22. (ntl)
|
Filing 163
Letter to The Honorable Gregory B. Williams from Richard C. Weinblatt regarding Discovery Dispute - re #162 Letter,. (Weinblatt, Richard)
|
Filing 162
[SEALED] Letter to The Honorable Gregory B. Williams from Gregory R. Booker regarding Discovery Dispute Regarding Motion to Compel Discovery - re 160 Order, Set Hearings. (Attachments: #1 Exhibits 1-5, #2 Text of Proposed Order)(Booker, Gregory)
|
Filing 161
ORAL ORDER: IT IS HEREBY ORDERED that the Markman Hearing set for 10/12/2022 will begin at 10:00 AM in Courtroom 6B. ORDERED by Judge Gregory B. Williams on 9/16/22. (ntl)
|
Filing 160
ORAL ORDER: IT IS HEREBY ORDERED that the Discovery Conference scheduled for 9/29/2022 at 2:00 PM will take place in Courtroom 6B before Judge Gregory B. Williams. ORDERED by Judge Gregory B. Williams on 9/16/22. (ntl)
|
Filing 159
NOTICE OF SERVICE of Defendant Zenara Pharma Private Limited's Second Supplemental Responses to Plaintiffs' First Set of Common Interrogatories (Nos. 1-7) filed by Zenara Pharma Private Limited.(Schladweiler, Benjamin)
|
Filing 158
ORAL ORDER: Counsel for the parties are HEREBY ORDERED to coordinate and deliver to Chambers by 1:00 pm on Monday, September 19 two (2) paper courtesy copies of D.I. 133 and D.I. 134 with all exhibits attached. All courtesy copies should include hard tabs before exhibits for easy reference. ORDERED by Judge Gregory B. Williams on 9/16/22. (ntl)
|
Filing 157
NOTICE OF SERVICE of Defendant MSN Second Supplemental Responses and Objections to Plaintiffs' First Set of ROGs (Nos. 1-7) filed by MSN Laboratories Private Limited.(Neff, Carl)
|
Filing 156
NOTICE OF SERVICE of Defendant RK Pharma Inc.'s Supplemental Responses and Objections to Plaintiffs' First Set of Common Interrogatories (Nos. 1-7) filed by RK Pharma, Inc..(Dorsney, Kenneth)
|
Case Reassigned to Judge Gregory B Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (apk)
|
Filing 155
MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Myer, R.)
|
Filing 154
MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Myer, R.)
|
SO ORDERED, re #154 MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz, filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., and #155 MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan, filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. Signed by Judge Richard G. Andrews on 9/1/2022. (nms)
|
Pro Hac Vice Attorney Michael P. Hogan and Timothy H. Kratz for Aurobindo Pharma Limited and Aurobindo Pharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
|
Filing 153
NOTICE OF SERVICE of Plaintiffs' Second Set of Requests For Production to MSN Laboratories Private Limited (Nos. 46-47); Plaintiffs' Second Set of Requests for Production to Prinston Pharmaceutical, Inc. (Nos. 51-52); and Plaintiffs' Second Set of Requests for Production to Zenara Pharma Private Limited (Nos. 46-47) filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 152
NOTICE of Withdrawal of Counsel by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc. (Connolly, Arthur)
|
Filing 151
NOTICE OF SERVICE of Defendant Prinstons Supplemental Objection and Response to Plaintiffs First Set of Common Interrogatories (No. 1-7) filed by Prinston Pharmaceutical, Inc..(Weinblatt, Richard)
|
Filing 150
NOTICE of Appearance by R. Touhey Myer on behalf of Aurobindo Pharma Limited, Aurobindo Pharma USA Inc. (Myer, R.)
|
Filing 149
NOTICE OF SERVICE of Aurobindo Pharma, Ltd. and Aurobindo Pharma USA, Inc.'s Supplemental Responses and Objections to Plaintiffs' First Set of Common Interrogatories to Defendants (Nos. 1-7) and Supplemental Responses and Objections to Plaintiffs' Common Interrogatories (No. 8) filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Connolly, Arthur)
|
Filing 148
ORAL ORDER: The Markman Hearing is now rescheduled for 10/12/2022, at 9:00 AM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 8/29/2022. (nms)
|
Filing 147
ORAL ORDER: The parties have advised that a dispute has arisen requiring judicial attention. The Court will hold a discovery conference on 9/29/2022, at 2:00 PM in Courtroom 6A. In preparation for this conference the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Scheduling Order. Ordered by Judge Richard G. Andrews on 8/19/2022. (nms)
|
Filing 146
NOTICE of Appearance by Richard Charles Weinblatt on behalf of Prinston Pharmaceutical, Inc. (Weinblatt, Richard)
|
Filing 145
NOTICE of Appearance by Renee Mosley Delcollo on behalf of Zenara Pharma Private Limited (Delcollo, Renee)
|
Filing 144
ORAL ORDER: Due to a scheduling conflict the Markman Hearing scheduled for 8/22/2022, is CANCELED. The hearing will be rescheduled for a date to be determined. Ordered by Judge Richard G. Andrews on 8/17/2022. (nms)
|
Filing 143
MOTION for Pro Hac Vice Appearance of Attorney Joshua Rosefelt - filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Gupta Fiorella, Nitika)
|
SO ORDERED, re #143 MOTION for Pro Hac Vice Appearance of Attorney Joshua Rosefelt, filed by Newron Pharmaceuticals S.p.A., MDD US Operations, LLC, Zambon S.p.A.. Signed by Judge Richard G. Andrews on 8/17/2022. (nms)
|
Filing 142
STIPULATION TO EXTEND TIME deadline for completion of document production to September 30, 2022 - filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Gupta Fiorella, Nitika)
|
SO ORDERED, re #142 STIPULATION and Proposed Order to Amend Scheduling Order deadline for completion of document production to September 30, 2022. Signed by Judge Richard G. Andrews on 8/3/2022. (nms)
|
Filing 141
NOTICE OF SERVICE of Defendant Prinstons Supplemental Objection and Response to Plaintiffs First Set of Common Interrogatories (No. 1-7) filed by Prinston Pharmaceutical, Inc..(Weinblatt, Richard)
|
Filing 140
NOTICE OF SERVICE of Defendant MSN's Supplemental Responses & Objections to Interrogatories filed by MSN Laboratories Private Limited.(Neff, Carl)
|
Filing 139
NOTICE OF SERVICE of Plaintiffs' First Supplemental Objections and Responses to Defendants' First Set of Common Interrogatories (Nos. 1, 3, 4, 6-10) and Plaintiffs' First Supplemental Objections and Responses to Defendants' First Set of Common Interrogatories (No. 2) filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 138
NOTICE OF SERVICE of Defendant Zenara Pharma Private Limited's First Supplemental Response to Interrogatory No. 1 of Plaintiff's First Set of Common Interrogatories (Nos. 1-7) filed by Zenara Pharma Private Limited.(Schladweiler, Benjamin)
|
Filing 137
NOTICE OF SERVICE of RK Pharma's First Supplemental Response to Plaintiffs' Second Set of Common Interrogatories (No. 8) filed by RK Pharma, Inc..(Dorsney, Kenneth)
|
Filing 136
NOTICE OF SERVICE of Supplementation of Aurobindo's Responses & Objections to Plaintiffs' First Set of Common Interrogatories to Defendants (No. 1) filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Connolly, Arthur)
|
Filing 135
ORDER Granting #132 Joint Motion For Claim Construction. Signed by Judge Richard G. Andrews on 7/27/2022. (nms)
|
Filing 134
Joint Appendix re #133 Joint Claim Construction Brief, by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Attachments: #1 Exhibit X, #2 Exhibit Y, #3 Exhibit Z, #4 Exhibit AA, #5 Exhibit BB, #6 Exhibit CC, #7 Exhibit DD, #8 Exhibit EE, #9 Exhibit FF, #10 Exhibit GG, #11 Exhibit HH, #12 Exhibit II, #13 Exhibit JJ, #14 Exhibit KK, #15 Exhibit LL, #16 Exhibit MM, #17 Exhibit NN, #18 Exhibit OO, #19 Exhibit PP, #20 Exhibit QQ, #21 Exhibit RR, #22 Exhibit SS)(Gupta Fiorella, Nitika) Modified on 7/26/2022 (nms).
|
Filing 133
JOINT Claim Construction Brief, filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Gupta Fiorella, Nitika) Modified on 7/26/2022 (nms).
|
Filing 132
Joint Motion For Claim Construction - filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Gupta Fiorella, Nitika) Modified on 7/26/2022 (nms).
|
Filing 131
NOTICE OF SERVICE of Plaintiffs' Responses to Defendants' 2nd Set of Common Requests For Production (Nos. 73-76); Responses to Defendants' First Set of Common Requests for Admission (Nos. 1-13); and Plaintiffs' Responses to Defendants' Second Set of Common Interrogatories (Nos. 11-12) filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Booker, Gregory)
|
Filing 130
NOTICE OF SERVICE of Defendants Aurobindo Pharma, Ltd. and Aurobindo Pharma USA, Inc.'s Responses and Objections to Plaintiffs' Second Set of Common Interrogatories to Defendants (No. 8) filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Connolly, Arthur)
|
Filing 129
NOTICE OF SERVICE of Defendant Prinstons Objection and Response to Plaintiffs Second Set of Common Interrogatories (No. 8) filed by Prinston Pharmaceutical, Inc..(Weinblatt, Richard)
|
Filing 128
NOTICE OF SERVICE of Defendant MSN Laboratories Private Limiteds Response and Objections to Plaintiffs Second Set of Common Interrogatories (No. 8) filed by MSN Laboratories Private Limited.(Neff, Carl)
|
Filing 127
NOTICE OF SERVICE of Response to second set of common interrogatories (No. 8) filed by RK Pharma, Inc..(Hitch, Cortlan)
|
Filing 126
NOTICE OF SERVICE of Defendant Zenera Pharma Private Limited's Objections and Response to Plaintiffs' Second Set of Common Interrogatories (No. 8) filed by Zenara Pharma Private Limited.(Schladweiler, Benjamin)
|
Filing 125
NOTICE of Change of Address by Carl Douglas Neff (Neff, Carl)
|
Filing 124
NOTICE OF SERVICE of 1. Defendants' Second Set of Common Requests for Production to Plaintiffs, 2. Defendants' First Set of Common Requests for Admission to Plaintiffs, 3. Defendants' Second Set of Common Interrogatories to Plaintiffs filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., MSN Laboratories Private Limited, Prinston Pharmaceutical, Inc., RK Pharma, Inc., Zenara Pharma Private Limited.(Schladweiler, Benjamin)
|
Filing 123
NOTICE OF SERVICE of Plaintiffs' Second Set of Common Interrogatories to Defendants (No. 8) filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Pro Hac Vice Attorney Brent A. Batzer for Prinston Pharmaceutical, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
|
Filing 122
NOTICE OF SERVICE of Plaintiffs' Supplemental Claim Charts to Prinston Pharmaceutical, Inc. filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 121
NOTICE OF SERVICE of Defendant RK Pharma, Inc.'s First Supplemental Initial Invalidity Contentions filed by RK Pharma, Inc..(Dorsney, Kenneth)
|
Pro Hac Vice Attorney Lina Genovesi for Aurobindo Pharma Limited, Aurobindo Pharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
|
Filing 120
Joint Claim Construction Chart, by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Attachments: #1 Appendix, #2 Exhibit A, #3 Exhibit B, #4 Exhibit C, #5 Exhibit D, #6 Exhibit E, #7 Exhibit F, #8 Exhibit G, #9 Exhibit H, #10 Exhibit I, #11 Exhibit J, #12 Exhibit K, #13 Exhibit L, #14 Exhibit M, #15 Exhibit N, #16 Exhibit O, #17 Exhibit P, #18 Exhibit Q, #19 Exhibit R, #20 Exhibit S, #21 Exhibit T, #22 Exhibit U, #23 Exhibit V, #24 Exhibit W)(Gupta Fiorella, Nitika) Modified on 5/16/2022 (nms).
|
Filing 119
Letter to The Honorable Richard G. Andrews, from Nitika Gupta Fiorella, regarding claim construction. (Gupta Fiorella, Nitika) Modified on 5/13/2022 (nms).
|
Filing 118
MOTION for Pro Hac Vice Appearance of Attorney Lina Genovesi - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Connolly, Arthur)
|
SO ORDERED, re #118 MOTION for Pro Hac Vice Appearance of Attorney Lina Genovesi, filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. Signed by Judge Richard G. Andrews on 5/5/2022. (nms)
|
Filing 117
NOTICE OF SERVICE of Supplemental Invalidity Contentions filed by Prinston Pharmaceutical, Inc..(Weinblatt, Richard)
|
Filing 116
NOTICE of Service of Supplemental Invalidity Contentions by Zenara Pharma Private Limited (Schladweiler, Benjamin)
|
Filing 115
NOTICE OF SERVICE of Plaintiffs' Initial Identification of Claim Terms and Proposed Constructions filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 114
NOTICE of Withdrawal of Kelly M. Conlan as Counsel for Defendants Aurobindo Pharma USA Inc. and Aurobindo Pharma Ltd. by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc. (Connolly, Arthur)
|
CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's #Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. 652(b). (Taylor, Daniel)
|
Filing 113
NOTICE OF SERVICE of Defendant RK Pharma, Inc.'s Initial Invalidity Contentions with Prior Art filed by RK Pharma, Inc..(Dorsney, Kenneth)
|
Filing 112
SO ORDERED Granting #111 Stipulation and Proposed Order to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 4/1/2022. (nms)
|
Filing 111
STIPULATION and Proposed Order to Amend Scheduling Order, by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Gupta Fiorella, Nitika) Modified on 4/1/2022 (nms).
|
Filing 110
NOTICE OF SERVICE of Defendants Aurobindo Pharma USA Inc., Aurobindo Pharma LTD., and MSN Laboratories Private Limited's Initial Invalidity Contentions filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., MSN Laboratories Private Limited.(Connolly, Arthur)
|
Filing 109
STIPULATION TO EXTEND TIME Initial Invalidity Contentions and Accompanying Document Production to April 1, 2022 - filed by RK Pharma, Inc.. (Dorsney, Kenneth)
|
SO ORDERED, re #109 STIPULATION TO EXTEND TIME Initial Invalidity Contentions and Accompanying Document Production to April 1, 2022. Signed by Judge Richard G. Andrews on 3/29/2022. (nms)
|
SO ORDERED, re #108 STIPULATION TO EXTEND TIME for Defendant MSN to serve its Initial Invalidity Contentions and Accompanying Document Production to March 29, 2022. Signed by Judge Richard G. Andrews on 3/24/2022. (nms)
|
Filing 108
STIPULATION TO EXTEND TIME for Defendant MSN to serve its Initial Invalidity Contentions and Accompanying Document Production to March 29, 2022 - filed by MSN Laboratories Private Limited. (Neff, Carl)
|
Filing 107
SO ORDERED Granting #106 Stipulation and Proposed Order of Dismissal Without Prejudice (*Party Optimus Pharma Pvt Ltd terminated). Signed by Judge Richard G. Andrews on 3/22/2022. (nms)
|
Filing 106
STIPULATION and [Proposed] Order of Dismissal Without Prejudice, by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Gupta Fiorella, Nitika) Modified on 3/22/2022 (nms).
|
Filing 105
NOTICE OF SERVICE of Initial Invalidity Contentions filed by Prinston Pharmaceutical, Inc..(Weinblatt, Richard)
|
Filing 104
NOTICE OF SERVICE of Initial Invalidity Contentions filed by Zenara Pharma Private Limited.(Schladweiler, Benjamin)
|
Filing 103
STIPULATION TO EXTEND TIME for Optimus Pharma Pvt. Ltd. to serve its Initial Invalidity Contentions and Accompanying Document Production to March 29, 2022 - filed by Optimus Pharma Pvt Ltd. (Myer, R.)
|
Filing 102
STIPULATION TO EXTEND TIME RK Pharma to serve its Initial Invalidity Contentions and Accompanying Document Production to March 29, 2022 - filed by RK Pharma, Inc.. (Dorsney, Kenneth)
|
SO ORDERED, re #103 STIPULATION to serve its Initial Invalidity Contentions and Accompanying Document Production to March 29, 2022. Signed by Judge Richard G. Andrews on 3/18/2022. (nms)
|
SO ORDERED, re #102 STIPULATION TO EXTEND TIME RK Pharma to serve its Initial Invalidity Contentions and Accompanying Document Production to March 29, 2022. Signed by Judge Richard G. Andrews on 3/18/2022. (nms)
|
Filing 101
STIPULATION TO EXTEND TIME to Serve Invalidity Contentions to March 29, 2022 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Connolly, Arthur)
|
SO ORDERED, re #101 STIPULATION TO EXTEND TIME to Serve Invalidity Contentions to March 29, 2022. Signed by Judge Richard G. Andrews on 3/17/2022. (nms)
|
Filing 100
STIPULATION TO EXTEND TIME for Defendant MSN to serve its Initial Invalidity Contentions and Accompanying Document Production to March 25, 2022 - filed by MSN Laboratories Private Limited. (Neff, Carl)
|
SO ORDERED, re #100 STIPULATION and Proposed Order to Extend Time to serve Initial Invalidity Contentions and Accompanying Document Production to March 25, 2022. Signed by Judge Richard G. Andrews on 3/11/2022. (nms)
|
Filing 99
NOTICE requesting Clerk to remove Lindsay Eastman as co-counsel. Reason for request: no longer affiliated with Upadhye Tang LLP. (Weinblatt, Richard)
|
Filing 98
NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants First Set of Common Requests For Production (Nos. 1-72) and Plaintiffs' Objections and Responses to Defendants' First Set of Common Interrogatories (Nos. 1-10) filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 97
NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 96
CORRECTED NOTICE OF SERVICE of Defendants First Set of Common Interrogatories to Plaintiffs (Nos. 1-10), filed by Prinston Pharmaceutical, Inc..(Weinblatt, Richard) Modified on 2/1/2022 (nms).
|
Filing 95
NOTICE OF SERVICE of Defendants First Set of Common Interrogatories to Plaintiffs (Nos. 1-6) filed by Prinston Pharmaceutical, Inc..(Weinblatt, Richard)
|
Filing 94
NOTICE OF SERVICE of Defendants Aurobindo Pharma, Ltd. and Aurobindo Pharma USA, Inc.'s Responses to Plaintiffs' First Set of Common Interrogatories (Nos. 1-7) filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Connolly, Arthur)
|
Filing 93
NOTICE OF SERVICE of Defendant MSN Laboratories Private Limiteds Responses and Objections to Plaintiffs First Set of Common Interrogatories (Nos. 1-7) filed by MSN Laboratories Private Limited.(Neff, Carl)
|
Filing 92
NOTICE OF SERVICE of Defendants' First Set of Common Requests for Production to Plaintiffs (Nos. 1-72) filed by Zenara Pharma Private Limited.(Schladweiler, Benjamin)
|
Filing 91
NOTICE OF SERVICE of Defendant Prinstons Objections and Responses to Plaintiffs First Set of Common Interrogatories (Nos. 1-7 filed by Prinston Pharmaceutical, Inc..(Weinblatt, Richard)
|
Filing 90
NOTICE OF SERVICE of Defendants Aurobindo Pharma, Ltd. and Aurobindo Pharma USA, Inc.'s Responses and Objections to Plaintiffs' First Set of Requests for Production (Nos. 1-45) filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Connolly, Arthur)
|
Filing 89
STIPULATION TO EXTEND TIME for Defendant MSN to Serve its Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-7) to January 21, 2022 - filed by MSN Laboratories Private Limited. (Neff, Carl)
|
Filing 88
NOTICE OF SERVICE of Defendant, Optimus Pharma Pvt. Ltd.'s Responses and Objections to Plaintiffs' First Set of Common Interrogatories to Defendants (Nos. 1-7) filed by Optimus Pharma Pvt Ltd.(Myer, R.)
|
Filing 87
NOTICE OF SERVICE of Defendant Zenara Pharma Private Limited's Objections and Responses to Plaintiffs' First Set of Common Interrogatories (Nos. 1-7) filed by Zenara Pharma Private Limited.(Schladweiler, Benjamin)
|
Filing 86
STIPULATION TO EXTEND TIME for Defendants Aurobindo Pharma, Ltd. and Aurobindo Pharma USA, Inc. to Serve its Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-7) to January 21, 2022 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Connolly, Arthur)
|
SO ORDERED, re #89 STIPULATION TO EXTEND TIME for Defendant MSN to Serve its Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-7) to January 21, 2022. Signed by Judge Richard G. Andrews on 1/12/2022. (nms)
|
SO ORDERED, re #86 STIPULATION TO EXTEND TIME to Serve Responses to First Set of Interrogatories (Nos. 1-7) to January 21, 2022. Signed by Judge Richard G. Andrews on 1/12/2022. (nms)
|
Filing 85
NOTICE OF SERVICE of (1) RK Pharma's Responses and Objections to Plaintiffs' First Set of Requests for Production (Nos.1-45) and; (2) RK Pharma's Responses and Objections to Plaintiffs' First Set of Common Interrogatories (Nos. 1-7) filed by RK Pharma, Inc..(Dorsney, Kenneth)
|
Filing 84
NOTICE OF SERVICE of Defendant MSN's Responses and Objections to Plaintiffs' First Set of RFPs (Nos. 1-45) filed by MSN Laboratories Private Limited.(Neff, Carl)
|
CORRECTING ENTRY: The Notice of Service filed at D.I. 84 on 1/10/2022, has been removed from the docket per the filer's request. A corrected notice will be refiled. (nms)
|
Filing 83
NOTICE OF SERVICE of Defendant Prinstons Objections and Responses to Plaintiffs First Set of Requests to Defendant for the Production of Documents and Things (Nos. 1-50) filed by Prinston Pharmaceutical, Inc..(Weinblatt, Richard)
|
Filing 82
STIPULATION TO EXTEND TIME to Serve Responses to Plaintiffs' First Set of Requests for Production (Nos. 1-45) to January 10, 2022 - filed by MSN Laboratories Private Limited. (Neff, Carl)
|
Filing 81
NOTICE OF SERVICE of Defendant, Optimus Pharma Pvt. Ltd.'s Responses and Objections to Plaintiffs' First Set of Requests for Production (Nos. 1-45) filed by Optimus Pharma Pvt Ltd.(Myer, R.)
|
Filing 80
NOTICE OF SERVICE of Defendant Zenara Pharma Private Limited's Objections and Responses to Plaintiffs' First Set of Requests for Production (Nos. 1-45) filed by Zenara Pharma Private Limited.(Schladweiler, Benjamin)
|
SO ORDERED, re #82 STIPULATION TO EXTEND TIME to Serve Responses to Plaintiffs' First Set of Requests for Production (Nos. 1-45) to January 10, 2022. Signed by Judge Richard G. Andrews on 1/3/2022. (nms)
|
SO ORDERED, re #79 STIPULATION TO EXTEND TIME to Serve Responses to Plaintiffs' First Set of Requests for Production (Nos. 1-45) to January 12, 2022. Signed by Judge Richard G. Andrews on 12/29/2021. (nms)
|
Filing 79
STIPULATION TO EXTEND TIME to Serve Responses to Plaintiffs' First Set of Requests for Production (Nos. 1-45) to January 12, 2022 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Connolly, Arthur)
|
SO ORDERED, re #78 STIPULATION TO EXTEND TIME To File a Motion Pursuant to the Protective Order to January 7, 2022. Signed by Judge Richard G. Andrews on 12/28/2021. (nms)
|
Filing 78
STIPULATION TO EXTEND TIME To File a Motion Pursuant to the Protective Order to January 7, 2022 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Connolly, Arthur) Modified on 12/28/2021 (nms).
|
Pro Hac Vice Attorney Michael P. Hogan for Optimus Pharma Pvt Ltd added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
|
Filing 77
NOTICE OF SERVICE of Plaintiffs' First Set of Common Interrogatories to Defendants (Nos. 1-7) filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 76
SO ORDERED Granting #75 Proposed Stipulated Protective Order. Signed by Judge Richard G. Andrews on 12/7/2021. (nms)
|
Filing 75
PROPOSED Stipulated Protective Order, by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Gupta Fiorella, Nitika) Modified on 12/7/2021 (nms).
|
Filing 74
MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan - filed by Optimus Pharma Pvt Ltd. (Myer, R.)
|
Filing 73
NOTICE requesting Clerk to remove Michael P. Hogan as co-counsel.. (Dorsney, Kenneth)
|
SO ORDERED, re #74 MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan, filed by Optimus Pharma Pvt Ltd. Signed by Judge Richard G. Andrews on 12/6/2021. (nms)
|
Filing 72
NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Production (Nos. 1-45) to Aurobindo Pharma Limited and Aurobindo Pharma USA Inc., MSN Laboratories Private Limited, Optimus Pharma Pt Ltd., Prinston Pharmaceutical, Inc., RK Pharma Inc., and Zenara Pharma Private Limited filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Booker, Gregory)
|
Filing 71
NOTICE OF SERVICE of Defendant MSN's Core Technical Documents Pursuant to Paragraph 4(b) of the Default Standard for Discovery filed by MSN Laboratories Private Limited.(Neff, Carl)
|
Filing 70
STIPULATION and Proposed Order to Amend Scheduling Order, by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Gupta Fiorella, Nitika) Modified on 11/19/2021 (nms).
|
SO ORDERED, re #70 Stipulation and Proposed Order to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 11/19/2021. (nms)
|
Filing 69
NOTICE OF SERVICE of Defendant's Core Technical Documents Pursuant to Paragraph 4(b) of the Default Standard for Discovery filed by Optimus Pharma Pvt Ltd.(Myer, R.)
|
Filing 68
NOTICE OF SERVICE of Defendant RK Pharma, Inc.'s Core Technical Documents filed by RK Pharma, Inc..(Dorsney, Kenneth)
|
SO ORDERED, re #67 STIPULATION to Extend Time for MSN to produce its ANDA and DMF to 11/26/2021. Signed by Judge Richard G. Andrews on 11/12/2021. (nms)
|
Filing 67
STIPULATION TO EXTEND TIME for MSN to produce its ANDA and DMF to 11/26/2021 - filed by MSN Laboratories Private Limited. (Neff, Carl)
|
Filing 66
NOTICE of Change of Address by R. Touhey Myer (Myer, R.)
|
Filing 65
NOTICE OF SERVICE of Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by MSN Laboratories Private Limited.(Neff, Carl)
|
Filing 64
NOTICE OF SERVICE of Defendant Prinstons Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Prinston Pharmaceutical, Inc..(Stamoulis, Stamatios)
|
Filing 63
NOTICE OF SERVICE of Plaintiff's Initial Identification of Accused Products and Asserted Patent and Plaintiffs' ESI Disclosures filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Booker, Gregory)
|
Filing 62
STIPULATION TO EXTEND TIME to submit MSN's Para. 3 Initial Disclosures to Nov. 1, 2021 - filed by MSN Laboratories Private Limited. (Neff, Carl)
|
Filing 61
NOTICE OF SERVICE of Paragraph 3 Initial Disclosures filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Connolly, Arthur)
|
Filing 60
NOTICE OF SERVICE of Paragraph 3 Disclosures Pursuant to the Delaware Default Standard for Discovery filed by RK Pharma, Inc..(Hitch, Cortlan)
|
SO ORDERED, re #62 STIPULATION and Proposed Order to Extend Time to submit MSN's Para. 3 Initial Disclosures to Nov. 1, 2021. Signed by Judge Richard G. Andrews on 10/29/2021. (nms)
|
Filing 59
NOTICE OF SERVICE of Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery by Defendant Optimus Pharma Pvt. Ltd. filed by Optimus Pharma Pvt Ltd.(Myer, R.)
|
SO ORDERED, re #58 Stipulation and Proposed Order to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 10/21/2021. (nms)
|
Filing 58
Stipulation and Proposed Order to Amend Scheduling Order, MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Booker, Gregory) Modified on 10/21/2021 (nms).
|
Filing 57
MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan - filed by RK Pharma, Inc.. (Dorsney, Kenneth)
|
SO ORDERED, re #57 MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan, filed by RK Pharma, Inc.. Signed by Judge Richard G. Andrews on 10/18/2021. (nms)
|
Filing 56
NOTICE OF SERVICE of Initial Disclosures Pursuant to Rule 26(a)(1) filed by Prinston Pharmaceutical, Inc..(Stamoulis, Stamatios)
|
Filing 55
NOTICE OF SERVICE of Rule 26(a)(1) Initial Disclosures filed by MSN Laboratories Private Limited.(Neff, Carl)
|
Filing 54
NOTICE OF SERVICE of Defendant Zenara Pharma Private Limited's Initial Disclosures and Paragraph 3 Disclosures filed by Zenara Pharma Private Limited.(Schladweiler, Benjamin)
|
Filing 53
NOTICE OF SERVICE of Initial Disclosures filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika)
|
Filing 52
NOTICE OF SERVICE of Rule 26(a)(1) Initial Disclosures filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Connolly, Arthur)
|
Filing 51
NOTICE OF SERVICE of Rule 26(a)(1) Initial Disclosures of Defendant, Optimus Pharma Pvt. Ltd. filed by Optimus Pharma Pvt Ltd.(Myer, R.)
|
Filing 50
NOTICE OF SERVICE of initial disclosures pursuant to F.R.C.P. 26(a)(1) filed by RK Pharma, Inc..(Dorsney, Kenneth)
|
Filing 49
MOTION for Pro Hac Vice Appearance of Attorney Julia S. Kim - filed by Zenara Pharma Private Limited. (Attachments: #1 Certification by Counsel)(Schladweiler, Benjamin)
|
Filing 48
ORAL ORDER: The Rule 16(b) Conference scheduled for 9/30/2021, is CANCELED. Ordered by Judge Richard G. Andrews on 9/29/2021. (nms)
|
Filing 47
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 5/25/2022. Amended Pleadings due by 5/25/2022. Discovery due by 1/27/2023. A Status Conference is set for 10/6/2023, at 9:00 AM in Courtroom 6A. Joint Claim Construction Brief due by 7/12/2022. A Markman Hearing is set for 8/22/2022, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 12/8/2023, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 1/8/2024, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 9/29/2021. (nms)
|
Pro Hac Vice Attorney Sarah E. Jack for MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
|
CASE REFERRED to Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at # https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (Taylor, Daniel)
|
SO ORDERED, re #49 MOTION for Pro Hac Vice Appearance of Attorney Julia S. Kim, filed by Zenara Pharma Private Limited. Signed by Judge Richard G. Andrews on 9/29/2021. (nms)
|
ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Should any party (or all parties) desire to discuss mediation and its timing, the party(ies) shall contact Judge Thynge and her Law Clerk, Daniel Taylor (#[email protected]), to request that a teleconference be scheduled. Ordered by Judge Mary Pat Thynge on 9/29/2021. (Taylor, Daniel)
|
SO ORDERED, re #46 MOTION for Pro Hac Vice Appearance of Attorney Sarah Jack, filed by Newron Pharmaceuticals S.p.A., MDD US Operations, LLC, Zambon S.p.A.. Signed by Judge Richard G. Andrews on 9/29/2021. (nms)
|
Filing 46
MOTION for Pro Hac Vice Appearance of Attorney Sarah Jack - filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Gupta Fiorella, Nitika)
|
Filing 45
PROPOSED Scheduling Order, by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.. (Gupta Fiorella, Nitika) Modified on 9/28/2021 (nms).
|
Filing 44
Letter to The Honorable Richard G. Andrews, from Nitika Gupta Fiorella, regarding Dial-in and Passcode for Rule 16(b) Telephonic Scheduling Conference. (Gupta Fiorella, Nitika) Modified on 9/28/2021 (nms).
|
Filing 43
ANSWER to #37 Answer to Complaint, and Counterclaim, by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika) Modified on 9/14/2021 (nms).
|
Filing 42
ANSWER to #38 Answer to Complaint, and Counterclaims, by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika) Modified on 9/14/2021 (nms).
|
Pro Hac Vice Attorneys Gary Ji and Gurpreet S. Walia for MSN Laboratories Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
|
Filing 41
ANSWER to #27 Answer to Complaint, and Counterclaims, by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A..(Gupta Fiorella, Nitika) Modified on 8/31/2021 (nms).
|
Filing 40
Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 9/30/2021, at 3:30 PM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 8/27/2021. (nms)
|
Filing 39
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Connolly, Arthur)
|
Filing 38
ANSWER to #1 Complaint, with Jury Demand , COUNTERCLAIM against MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A. by Optimus Pharma Pvt Ltd.(Myer, R.)
|
Filing 37
ANSWER to #1 Complaint, , COUNTERCLAIM against Aurobindo Pharma USA Inc., Aurobindo Pharma Limited by Aurobindo Pharma USA Inc., Aurobindo Pharma Limited.(Connolly, Arthur)
|
Pro Hac Vice Attorney James E. Nealon,Steven J. Moore for Aurobindo Pharma Limited,for Aurobindo Pharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
|
SO ORDERED, re #36 MOTION for Pro Hac Vice Appearance of Attorney Steven J. Moore and James E. Nealon, filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. Signed by Judge Richard G. Andrews on 8/23/2021. (nms)
|
Filing 36
MOTION for Pro Hac Vice Appearance of Attorney Steven J. Moore and James E. Nealon - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Connolly, Arthur)
|
Filing 35
MOTION for Pro Hac Vice Appearance of Attorney Gurpreet Singh Walia, M.D. - filed by MSN Laboratories Private Limited. (Neff, Carl)
|
Filing 34
MOTION for Pro Hac Vice Appearance of Attorney Gongjun ("Gary") Ji - filed by MSN Laboratories Private Limited. (Neff, Carl)
|
SO ORDERED, re #34 MOTION for Pro Hac Vice Appearance of Attorney Gongjun ("Gary") Ji, filed by MSN Laboratories Private Limited, #35 MOTION for Pro Hac Vice Appearance of Attorney Gurpreet Singh Walia, M.D., filed by MSN Laboratories Private Limited. Signed by Judge Richard G. Andrews on 8/17/2021. (nms)
|
SO ORDERED, re #31 STIPULATION to Extend Time (*Reset Answer Deadlines: Optimus Pharma Pvt Ltd answer due 8/24/2021). Signed by Judge Richard G. Andrews on 8/11/2021. (nms)
|
Filing 33
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by MSN Laboratories Private Limited. (Neff, Carl)
|
Filing 32
ANSWER to #1 Complaint, by MSN Laboratories Private Limited.(Neff, Carl)
|
Filing 31
STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to the Complaint to August 24, 2021 - filed by Optimus Pharma Pvt Ltd. (Myer, R.)
|
Filing 30
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Optimus Pharma Pvt Ltd. (Myer, R.)
|
Filing 29
NOTICE of Appearance by R. Touhey Myer on behalf of Optimus Pharma Pvt Ltd (Myer, R.)
|
Filing 28
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zhejiang Huahai Pharmaceutical Co., Ltd. for Prinston Pharmaceutical, Inc. filed by Prinston Pharmaceutical, Inc.. (Stamoulis, Stamatios)
|
Filing 27
ANSWER to #1 Complaint, with Jury Demand and COUNTERCLAIMS against MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A., by Prinston Pharmaceutical, Inc..(Stamoulis, Stamatios) Modified on 8/10/2021 (nms).
|
Filing 26
NOTICE of Appearance by Carl Douglas Neff on behalf of MSN Laboratories Private Limited (Neff, Carl)
|
Filing 25
STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to the Complaint to August 24, 2021 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Connolly, Arthur)
|
Filing 24
NOTICE of Appearance by Kelly M. Conlan on behalf of Aurobindo Pharma Limited, Aurobindo Pharma USA Inc. (Conlan, Kelly)
|
Filing 23
NOTICE of Appearance by Arthur G. Connolly, III on behalf of Aurobindo Pharma Limited, Aurobindo Pharma USA Inc. (Connolly, Arthur)
|
Filing 22
MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III and Attorney Timothy H. Kratz - filed by RK Pharma, Inc.. (Dorsney, Kenneth)
|
SO ORDERED, re #25 STIPULATION to Extend Time (*Reset Answer Deadlines: Aurobindo Pharma Limited answer due 8/24/2021; Aurobindo Pharma USA Inc. answer due 8/24/2021). Signed by Judge Richard G. Andrews on 8/4/2021. (nms)
|
SO ORDERED, re #22 MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III and Attorney Timothy H. Kratz, filed by RK Pharma, Inc.. Signed by Judge Richard G. Andrews on 8/4/2021. (nms)
|
Filing 21
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by RK Pharma, Inc.. (Hitch, Cortlan)
|
Filing 20
ANSWER to #1 Complaint, by RK Pharma, Inc..(Hitch, Cortlan)
|
Filing 19
MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff, Ph.D., Edward Pergament and Kenneth Canfield - filed by Zenara Pharma Private Limited. (Attachments: #1 Certification by Dmitry V. Shelhoff, Ph.D., #2 Certification by Edward Pergament, #3 Certification by Kenneth Canfield)(Schladweiler, Benjamin)
|
SO ORDERED, re #19 MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff, Ph.D., Edward Pergament and Kenneth Canfield, filed by Zenara Pharma Private Limited. Signed by Judge Richard G. Andrews on 7/20/2021. (nms)
|
Pro Hac Vice Attorney Kenneth S. Canfield for Zenara Pharma Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
|
Pro Hac Vice Attorney Dmitry V. Shelhoff for Zenara Pharma Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
|
Pro Hac Vice Attorney Edward D. Pergament for Zenara Pharma Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
|
Filing 18
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Biophore India Pharmaceuticals Private Ltd. for Zenara Pharma Private Limited filed by Zenara Pharma Private Limited. (Schladweiler, Benjamin)
|
Filing 17
ANSWER to #1 Complaint, by Zenara Pharma Private Limited.(Schladweiler, Benjamin)
|
Pro Hac Vice Attorney Yixin H. Tang for Prinston Pharmaceutical, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk)
|
Filing 16
WAIVER OF SERVICE returned executed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.: For MSN Laboratories Private Limited waiver sent on 6/11/2021, answer due 8/10/2021. (Booker, Gregory)
|
Filing 15
WAIVER OF SERVICE returned executed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.: For Aurobindo Pharma Limited waiver sent on 6/11/2021, answer due 8/10/2021; Aurobindo Pharma USA Inc. waiver sent on 6/11/2021, answer due 8/10/2021. (Booker, Gregory)
|
Pro Hac Vice Attorney Lindsay Eastman for Prinston Pharmaceutical, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (smg)
|
Filing 14
WAIVER OF SERVICE returned executed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.: For Optimus Pharma Pvt Ltd waiver sent on 6/11/2021, answer due 8/10/2021. (Booker, Gregory)
|
Pro Hac Vice Attorney Shashank D. Upadhye for Prinston Pharmaceutical, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
|
Filing 13
WAIVER OF SERVICE returned executed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.: For RK Pharma, Inc. waiver sent on 6/11/2021, answer due 8/10/2021. (Booker, Gregory)
|
SO ORDERED, re #10 MOTION for Pro Hac Vice Appearance of Attorney Shashank Upadhye, Yixin Tang, Brent Batzer, and Lindsay Eastman, filed by Prinston Pharmaceutical, Inc.. Signed by Judge Richard G. Andrews on 6/16/2021. (nms)
|
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
|
Filing 12
WAIVER OF SERVICE returned executed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.: For Prinston Pharmaceutical, Inc. waiver sent on 6/11/2021, answer due 8/10/2021. (Booker, Gregory)
|
Filing 11
WAIVER OF SERVICE returned executed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A.: For Zenara Pharma Private Limited waiver sent on 6/11/2021, answer due 8/10/2021. (Booker, Gregory)
|
Filing 10
MOTION for Pro Hac Vice Appearance of Attorney Shashank Upadhye, Yixin Tang, Brent Batzer, and Lindsay Eastman - filed by Prinston Pharmaceutical, Inc.. (Stamoulis, Stamatios)
|
Filing 9
NOTICE of Appearance by Stamatios Stamoulis on behalf of Prinston Pharmaceutical, Inc. (Stamoulis, Stamatios)
|
Filing 8
NOTICE of Appearance by Elizabeth M. Flanagan on behalf of All Plaintiffs (Flanagan, Elizabeth)
|
Filing 7
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zambon Company S.p.A. for Zambon S.p.A. - filed by Zambon S.p.A. (kmd)
|
Filing 6
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed - filed by Newron Pharmaceuticals S.p.A. (kmd)
|
Filing 5
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Supernus Pharmaceuticals, Inc. for MDD US Operations, LLC - filed by MDD US Operations, LLC. (kmd)
|
Filing 4
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,076,515; US 8,278,485; US 8,283,380. (kmd)
|
Filing 3
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 9/22/2024. (kmd)
|
Filing 2
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd)
|
Filing 1
COMPLAINT for Patent Infringement filed with Jury Demand against Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., MSN Laboratories Private Limited, Optimus Pharma Pvt Ltd, Prinston Pharmaceutical, Inc., RK Pharma, Inc., Zenara Pharma Private Limited - Magistrate Consent Notice to Pltf. (Filing fee $402, receipt number ADEDC-3633393.) - filed by MDD US Operations, LLC, Newron Pharmaceuticals S.p.A, Zambon S.p.A. (Attachments: #1 Exhibits 1-6, #2 Civil Cover Sheet)(kmd)
|
No Summons Issued. (kmd)
|
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Pro Hac Vice Attorney Bonnie Fletcher Price for MDD US Operations, LLC, Newron Pharmaceuticals S.p.A., Zambon S.p.A. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)